Thomas G. Frinzi - Mar 12, 2024 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
President & CEO, Director
Signature
/s/ Nathaniel Sisitsky as attorney-in-fact for Thomas G. Frinzi
Stock symbol
STAA
Transactions as of
Mar 12, 2024
Transactions value $
$0
Form type
4
Date filed
3/14/2024, 05:20 PM
Previous filing
Jan 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Restricted Stock Units Award $0 +74.4K $0.00 74.4K Mar 12, 2024 Common Stock 74.4K $0.00 Direct F1, F2
transaction STAA Common Stock Options Award $0 +66.6K $0.00 66.6K Mar 12, 2024 Common Stock 66.6K $37.64 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting.
F2 RSUs granted to the Reporting Person on March 12, 2024. RSUs will vest as to 1/3 (24,796 shares) on March 12, 2025, 1/3 (24,796 shares) on March 12, 2026, and 1/3 (24,797 shares) on March 12, 2027.
F3 Stock options granted to the Reporting Person on March 12, 2024. Options will vest and become exercisable as to 1/3 (22,209 shares) on March 12, 2025, with the remaining 2/3 (44,418 shares) vesting and becoming exercisable monthly over the following 24 months in equal amounts on a monthly basis. In the event such amount does not evenly divide into 24 months, the remaining balance of options will vest and become exercisable on March 12, 2027.